Glycorex Transplantation – removing antibodies from blood to improve transplantation and fight autoimmune diseases

Glycorex’s unique molecular level technology that specifically selects and removes antibodies in the blood has opened up ground-breaking treatments and solutions in healthcare. The company’s medical devices enable transplants across the blood groups saving lives and providing health economic benefits by increasing the number of transplants. The company’s technology to treat blood is applied in several health care settings and a new disruptive product has recently been launched with the potential to increase availability of blood plasma. Several new products for the treatment of autoimmune diseases are under development.

Glycorex Transplantation - removing antibodies from blood to improve transplantation and fight autoimmune diseases

In addition to kidney transplants, our product, Glycosorb® ABO, is used in several other types of transplants, such as liver, heart and stem cell transplants. More than 60 scientific papers with Glycosorb® ABO show excellent short- and long-term results fully comparable to blood group compatible transplants. Thanks to Glycosorb® ABO, blood group incompatible transplants are now routinely performed in many countries.

With our unique technology as a base, we are currently expanding into new interesting applications. In the area of transfusion medicine, we have recently launched a product intended to be used for donated plasma to produce universal blood plasma which can be given regardless of the recipient’s blood group, which means major improvements in logistics, safety and availability.
The focus of our development work is now to develop new treatments for severe autoimmune diseases. The closest to launch is a specific treatment for rheumatoid arthritis (RA) – a disease that has affected around five million people in Europe.

Glycorex Transplantation AB (publ) is based in Lund, Sweden, and its shares are listed on NGM – Main Regulated, Stockholm (NGM: GTAB B).

Glycorex Transplantation – removing antibodies from blood to improve transplantation and fight autoimmune diseases

More info : Glycorex Transplantation AB

Keywords : transplantation, autoimmune diseases, Rheumatoid Arthritis, antibodies hematology

Newron Pharmaceuticals – innovative therapies for Central Nervous System

Newron Pharmaceuticals is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain.

Newron Pharmaceuticals – innovative therapies for Central Nervous System

Newron Pharmaceuticals

Continue reading

Merozyne – muscular dystrophy

Merozyne Therapeutics has been established to develop a treatment for MDC1A, a severe form of muscular dystrophy.

Merozyne – muscular dystrophy

merozyne

Continue reading

Bioinvent – antibody drug discovery

BioInvent is a research-based pharmaceutical company focused on discovery and development of innovative antibody-based drugs against cancer. BioInvent also develops antibody-based drugs in collaboration with partners who finance the development of new drugs and provide BioInvent with the right to milestone payments and royalties on sales.

Bioinvent – antibody drug discovery

Bioinvent

Continue reading

Swecure – immunoregulatory disorders

Swecure is a Swedish biotechnology company developing treatments for immunoregulatory disorders, such as allergy and IBD.

Swecure – immunoregulatory disorders

swecure AB

Continue reading

Saromics – structure-based drug design

SARomics Biostructures provides premium protein crystallization, protein crystallography and structure-based drug design outsourcing services.

Saromics – structure-based drug design

saromics

Continue reading

Gyros – miniaturized immunoassays

Gyros is a biotech company manufacturing laboratory instruments, consumables, kits and software to maximize laboratory productivity by miniaturizing and automating immunoassays at nanoliter-scale.

Gyros – miniaturized immunoassays

gyros

Continue reading

BioFunds.org – you can finance research for Free !

BioFunds.org – you can finance research for Free !

By using Biofunds for all your search on Google, PubMed or Protocols, you can help finance Science and Research ! For Free !

Continue reading

Denator – stabilizing the proteome

Based on its proprietary heat stabilization technology, Denator is a biotech company developing instruments and consumables to address needs in the life science and clinical research markets. Denator’s products enable scientists to stabilize biological samples (cellular biopsies or tissue sections). Normal degradation processes are stopped instantaneously and permanently, preventing the distortion of subsequent analytical results and thus revealing the true in vivo status of every sample.

Denator – stabilizing the proteome

denator Continue reading